Antitumorigenic Effects of ZAKβ, an Alternative Splicing Isoform of ZAK

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• The sterile alpha motif (SAM)- and leucine-zipper-containing kinase (ZAK) is implicated in cell cycle regulation and oncogenesis.
• ZAK gene expression yields two splice variants: ZAKα and ZAKβ.

Purpose of the Study:

• To investigate the distinct roles of ZAKα and ZAKβ in cancer.
• To explore the therapeutic potential of ZAKβ and its associated signaling pathways.

Main Methods:

• Analysis of ZAKα and ZAKβ protein expression in tumor and normal tissues.
• Ectopic expression of ZAKβ in cancer cells to assess its effects on proliferation and growth.
• Investigation of the ZAKβ:ZAKα ratio's impact on cAMP signaling and CREB1 activation.
• Treatment of cancer cells with doxorubicin to observe ZAK splicing changes and effects on growth.

Main Results:

• ZAKα proteins were upregulated in tumor tissues, while ZAKβ proteins were predominantly found in normal tissues.
• Ectopic ZAKβ expression inhibited cancer cell proliferation and anchorage-independent growth.
• The ZAKβ:ZAKα ratio regulated cAMP signaling; high ZAKβ activated CREB1 and showed antitumor properties.
• Overexpression of ZAKβ or CREB1 reduced cyclooxygenase 2 (Cox2) and β-catenin levels.
• Doxorubicin treatment induced a switch from ZAKα to ZAKβ expression, inhibiting cancer cell growth.

Conclusions:

• ZAKα and ZAKβ exhibit opposing functions in tumor cell proliferation, with ZAKβ possessing potent antitumor properties and ZAKα promoting tumor growth.
• ZAKβ's antitumor effects are mediated through the cAMP/CREB1 pathway, suppressing key oncogenic factors like Cox2 and β-catenin.
• Pharmacological manipulation of ZAK splicing represents a potential strategy to activate endogenous antitumorigenic properties.